Publications in peer-reviewed journals

1) YR Wang, H Zhao, XS Sheng, PE Gambino, B Costello, and K
Bojanowski: Protective effect of Fructus Lycii Polysaccharides against time- and
hyperthermia-induced damage in cultured seminiferous epithelium
J. Ethnopharmacol. 82:
169-175, 2002.

2) E Atlas, K Bojanowski, I Mehmi, R Lupu: A deletion mutant of heregulin increases the
sensitivity of breast cancer cells to chemotherapy without promoting tumorigenicity.
Oncogene. 22:3441-3451, 2003.

3) H Zhao, A Alexeev, E Chang, G Greenburg and K Bojanowski: Lycium barbarum
glycoconjugates: effect on whole skin and cultured dermal fibroblasts.
Phytomedicine, 12:
132-138, 2005.

4) H Zhao, F Aria, R Mortezaei, YR Wang, XS Sheng and K Bojanowski:
SBD.4 Stimulates Regenerative Processes In Vitro and Wound Healing in Genetically
Diabetic Mice and in Human Skin/SCID Mouse Chimera.
Wound Repair & Regeneration, 14:
593-601, 2006.

5) H Zhao, A Alexeev, V Sharma, LD Guzman, K Bojanowski: Effect of SBD.4A - a defined
multicomponent preparation of Angelica sinensis - in periodontal regeneration models.
Phytother Res. 22:923-928, 2008.

6) J Deneau, T Ahmed, R Blotsky, K Bojanowski: Anti-Diabetic Activity of a Mineraloid Isolate,
In Vitro and in Genetically Diabetic Mice.
Int. J. Vitam. Nutr. Res. (Switzerland). 81:1-8, 2011.

7) K Gobis, H Foks, K Bojanowski, E Augustynowicz-Kopeć, A Napiórkowska: Synthesis of
novel 3-cyclohexylpropanoic acid-derived nitrogen heterocyclic compounds and their
evaluation for tuberculostatic activity.
Bioorg Med Chem. 20:37-144, 2012.

8) H Zhao, J Deneau, G O L Che, S Li, F. Vagnini, P Azadi, R Sonon, R Ramjit, S M Y Lee
and K Bojanowski:
Angelica sinensis Isolate SBD.4: Composition, Gene Expression
Profiling, Mechanism of Action, and Effect on Wounds in Rats and Humans.
Eur. J.
22:58-67, 2012.

9) K Gobis, H Foks, J Sławiński, A Sikorski, D Trzybiński, E Augustynowicz-Kopeć, A
Napiórkowska, K Bojanowski: Synthesis and Biological Activity of Novel Heterocyclic
Monatshefte für Chemie – Chemical Monthly 144:647-658, 2013

10) K Bojanowski: Hypodermal delivery of cosmetic actives for improved facial skin
morphology and functionality.
Int J Cosmet Sci. doi: 10.1111/ics.12077, 2013.

11) RK Chaudhuri, K Bojanowski: Bakuchiol: a retinol-like functional compound revealed by
gene expression profiling and clinically proven to have anti-aging effects.
Int J Cosmet Sci.
221-230, 2014.

12) H Zhao, K Bojanowski: Hypodermis: the last frontier for facial cosmetics. H&PC Today 9:
38-42, 2014.

13) K Gobis, H Foks, K Suchan, E Augustynowicz-Kopeć, A Napiórkowska, K Bojanowski:
Novel 2-(2-phenalkyl)-1H-benzo[d]imidazoles as antitubercular agents. Synthesis,
biological evaluation and structure-activity relationship.
Bioorg Med Chem. pii: S0968-0896
(15)00173-X, 2015.

14) H Zhao, K Bojanowski: Dermatologic Uses and Effects of Lycium barbarum. In “Lycium
and human health” Ed. RCC Chang and K Fai, (Springer), 79-8, 2015.

15) K Bojanowski, R Bojanowski: Two methods of oral delivery of resveratrol: a case study.
Journal of Aging Research and Clinical Practice (JARCP), 4 (3), 185-189, 2015.

16) S Ma, K Gobis, WR Swindell, R Chaudhuri, R Bojanowski, K Bojanowski: Synthesis and
activity of the salicylic acid ester of bakuchiol in psoriasis-surrogate keratinocytes and skin
Clin Exp Dermatol. 42:251-260, 2017.

17) RK Chaudhuri, K Bojanowski: Improvement of Hydration and Epidermal Barrier Function
in Human Skin by a Novel Compound Isosorbide Dicaprylate.
Int J Cosmet Sci. 39:518-526,

Other Publications

G Gillis, K Bojanowski, G Majewski, R Bohm: UpRegulex - Sericin peptides from silk
Cosmetic Science Technology, 30-33, 2009.

R Chaudhuri, K Bojanowski, F. Marchio: Le rétinol et les composés rétinol-like en soins
Expressions Cosmetiques, 227-233, 2010

Presentations & Invited Lectures

K Bojanowski and H Zhao: Importance of glycosylation for the activity of a new anticancer
angiogenesis inhibitor SBD.1. Poster at Gordon
Conference on Carbohydrates, Tilton, 2001

K Bojanowski: Skin Care through the Protection of Dermal
Microcirculation. Invited lecture at Personal Care Ingredients
Technology Expo. New York, 2003

K Bojanowski: Product development for niche markets - in vitro validation
approach. Invited lecture at Personal Care Ingredients  Technology
Expo. New York, 2005

H Zhao, F Aria, V Sharma, A Alexeev, R Mortezaei and K Bojanowski: SBD.4 - A Modular
Technology for the Development of Products for Skin,
Wounds and Periodontal Diseases. UCSF 2006 Life Science Innovation Competition
Finals. San Francisco, 2006 (Presentation awarded People's Choice Award)

K Bojanowski: Hybrid Compounds: A Growing Trend in Cosmeceuticals. Strategic
Research Institute's (SRI) 4th Annual Cosmeceuticals Conference. New York, 2007  

K Bojanowski: Non-clinical Testing of Cosmetic Actives for Special Needs and Aging Skin.
Ingredient & Technology Conference New York, 2008.

K Bojanowski, J Deneau, OL Che, SMY Lee, F Vagnini and R Ramjit: SBD.4-Based Wound
Dressings: the “Green” Revolution in Chronic Ulcer
Management. Symposium on Advanced
Wound Care
, Anaheim, 2010.

K Gobis, H Foks, E Augustynowicz-Kopeć, and K Bojanowski. Synthesis and tuberculostatic
activity of novel 2-(2-cyclohexylethyl)-lH-benzo[ d]
imidazoles. Multidysciplinary Conference
on Drug Research,
Ossa, 2012.

BA Green, MS,BL. Edison, K Bojanowski; RL. Weinkauf. Antiaging bionic and polyhydroxy
acids reduce nonenzymatic protein glycation and skin sallowness. Journal of American
Academy of Dermay (JAAD) 70:5, Suppl. 1, p. AB22.

R Chaudhuri, K Bojanowski. Cyclobutane Pyrimidine Dimers, NADPH Oxidase and
Peroxynitrite: How Are They All Interlinked? 29th IFSCC Congress, Orlando, 2016.

WR Swindell, K Bojanowski, M Kindy, T Shum, R Chau, D Ko. GM604 for Parkinson's
Disease treatment: Pre-clinical findings and results from a pilot placebo-controlled trial.
F1000Research 6:28 (doi: 10.7490/f1000research.1113600. 1), 2017.

RK Chaudhuri, Krys Bojanowski, Parvesh Singh. Delayed DNA Damage - How Significant
this Pathway is for Skin Damage?
NYSCC Annnual Meeting presentation, 2017.

Mark Kindy, William R. Swindell, Krzysztof Bojanowski, Paul Lupinacci, Robert Bowser,
Raphael Nir, Tony Shum, Raymond Chau, Dorothy Ko. GM604 –An Endogenous Multiple-
Target Regulator that Provides a Novel Therapeutic Strategy for Treatment of ALS and Other
Neurodegenerative Diseases. 28th National Symposium on ALS/MND, Boston,


For the intellectual property portfolio of Sunny BioDiscovery please contact Dr. Krys
Bojanowski at
Sunny BioDiscovery, Inc.